ADVERTISEMENT
Mold-Tek Packaging Q4 Review: IDBI Capital Maintains 'Buy', Hikes Target Price Post Inline Results
Volume growth seems back on track, says IDBI Capital, maintaining 'Buy' on the stock
20 May 2025, 03:27 PM IST 
Save
Mold-Tek Packaging's pharma- Pack division sales almost tripled to Rs 66.7 million in Q4 FY25 compared to Q3 FY25, crossed breakeven and started contributing to the bottom line. (Source: Comapny website)
The brokerage continues to like Mold-Tek Packaging given its strategy of timely capacity expansion and entry into high value products. The management’s focus on high margin Food and FMCG, foray into pharma segment and timely capacity addition for paints division would pave the way for future earnings growth.
